CCBI Healthcare Fund makes two investments
CCB International, the investment arm of China Construction Bank, has made two investments in the medical sector, including an RMB150 million ($36.9 million) capital injection into Luyan, a medical company in Fujian, and an RMB100 million ($14.7 million) investment into Lerentang Pharmaceutical, a pharmaceutical distributor in Hebei.
CCMB admitted those investments, but declined to disclose further information. These investments were made from the CCBI Healthcare Fund, China’s first healthcare-focused fund and China Construction...
More on Expansion
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.